Marker Therapeutics, Inc. (MRKR)
NASDAQ · Healthcare
Marker Therapeutics, Inc. Total Liabilities 2017–2025
Marker Therapeutics, Inc. annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Marker Therapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 2.3M, a 34.36% decrease year-over-year.
- Marker Therapeutics, Inc. total liabilities for 2025 were 2.3M, a 34.36% decrease from 2024.
- Marker Therapeutics, Inc. total liabilities for 2024 were 3.5M, a 12.67% increase from 2023.
- Marker Therapeutics, Inc. total liabilities for 2023 were 3.1M, a 79.25% decrease from 2022.
- Marker Therapeutics, Inc. total liabilities for 2022 were 14.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Marker Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $2 |
| 2024 | $3 |
| 2023 | $3 |
| 2022 | $15 |
| 2021 | $24 |
| 2020 | $18 |
| 2019 | $2 |
| 2018 | $3 |
| 2017 | $2 |
| Marker Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $2 |
| 2024-12-31 | $3 |
| 2023-12-31 | $3 |
| 2022-12-31 | $15 |
| 2021-12-31 | $24 |
| 2020-12-31 | $18 |
| 2019-12-31 | $2 |
| 2018-12-31 | $3 |
| 2017-12-31 | $2 |
Marker Therapeutics, Inc. Total Liabilities — FAQ
Marker Therapeutics, Inc. (MRKR) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRKR's total liabilities history?
The chart and table above show Marker Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.